Stay updated with breaking news from Corp comms. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
UTRECHT, The Netherlands and CAMBRIDGE, Mass., April 03, 2024 (GLOBE NEWSWIRE) Merus N.V. (Nasdaq: MRUS), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today announced that Bill Lundberg, M.D., President, Chief Executive Officer of Merus, will participate in in a fireside chat at the 23rd Annual Needham Virtual Healthcare Conference on Wednesday, April 10, 2024 at 8:45 a.m. ET. The webcast of the presentation will b ....
EQSAdhoc PUMA SE Key word Share BuybackDividend PUMA SE PUMA plans to return up to 50% of net income to shareholders including share buybacks 29Feb2024 0934 CETCEST Disclosure of an inside informatio ....